Medx Health Corp MDX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MDX is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- CAD 0.09
- Day Range
- CAD 0.10–0.10
- 52-Week Range
- CAD 0.03–0.11
- Bid/Ask
- CAD 0.10 / CAD 0.10
- Market Cap
- CAD 26.20 Mil
- Volume/Avg
- 19,000 / 194,098
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 27.63
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Medx Health Corp is engaged in the development, manufacturing, and marketing of skin-related screening tools and phototherapy devices for pain relief and tissue repair. Its two main product lines are; SIAscopy, a medical device technology that is used to scan skin for suspicious moles and lesions; and Phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It derives key revenue from the sale of Phototherapeutic lasers. The company sells its products internationally, of which prime revenue is generated in Canada and the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- https://www.medxhealth.com
Valuation
|
Metric
|
MDX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 27.63 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
MDX
|
|---|---|
Quick Ratio | 0.03 |
Current Ratio | 0.09 |
Interest Coverage | −1.64 |
Quick Ratio
MDX
Profitability
|
Metric
|
MDX
|
|---|---|
Return on Assets (Normalized) | −568.39% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
MDX
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Nlvxfscl | Jsjbzs | $185.4 Bil | |
SYK
| Stryker Corp | Hrsddmfjqb | Ynby | $127.7 Bil | |
BSX
| Boston Scientific Corp | Pfrbfpmx | Mgxjrws | $107.6 Bil | |
MDT
| Medtronic PLC | Ltcnhvhs | Sfbjjz | $105.9 Bil | |
DXCM
| DexCom Inc | Ytxvqbdc | Fnln | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Dswhbwvlg | Gvhhwhq | $52.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Qgfmwpcvv | Qhzbr | $24.6 Bil | |
ALGN
| Align Technology Inc | Qfcrhkkxp | Bvcss | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Kjhvhfwm | Gwzlsg | $18.7 Bil | |
PODD
| Insulet Corp | Rjgfwdbg | Jrkyfcm | $11.6 Bil |